Samuel C. Blackman, HEAD OF R&D at Day One Biopharmaceuticals, Inc. (DAWN), sold 46,510 shares at $16.10 ($751K) on 2024-11-11, disclosed to the SEC on 2024-11-12.
Scheduled sale ($751k) by HEAD OF R&D under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.17 | 18,255 | $295K | 39.3% |
| 2 | $16.17 | 18,255 | $295K | 39.3% |
| 3 | $16.10 | 10,000 | $161K | 21.4% |
| Total | $16.15 avg | 46,510 | $751K | 100% |
| Filing → |
| DAWN | SELL | 2024-11-08 | $361K | — | Filing → |
| DAWN | SELL | 2024-11-04 | $8K | — | Filing → |
| DAWN | SELL | 2024-09-12 | $427K | — | Filing → |